Sign in

CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811384762
Phone
(302) 467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
  1. 4 Open-market sale President, CMO sold 13,280 shares at $6.12 ($81,274)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy CEO bought 19,188 shares at $5.13 ($98,446)
  11. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.76 ($47,600)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.23 ($42,300)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 5 of 10 · 185 filings